RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.6B
1-Year Return 25.98%
This Quarter Return
+33.41%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$2.57B
AUM Growth
+$452M
Cap. Flow
-$55.1M
Cap. Flow %
-2.14%
Top 10 Hldgs %
31.92%
Holding
139
New
6
Increased
46
Reduced
13
Closed
9

Top Buys

1
CVET
Covetrus, Inc. Common Stock
CVET
$20.7M
2
PTLA
Portola Pharmaceuticals, Inc.
PTLA
$20M
3
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$16.9M
4
CI icon
Cigna
CI
$14.5M
5
RARE icon
Ultragenyx Pharmaceutical
RARE
$10.8M

Top Sells

1
TSRO
TESARO, Inc.
TSRO
$44.7M
2
LOXO
Loxo Oncology, Inc
LOXO
$33.8M
3
MOH icon
Molina Healthcare
MOH
$19.1M
4
WCG
Wellcare Health Plans, Inc.
WCG
$18.7M
5
BIIB icon
Biogen
BIIB
$15M

Sector Composition

1 Healthcare 86.14%
2 Consumer Staples 0.39%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
DERM
76
DELISTED
Dermira, Inc.
DERM
$10.5M 0.4%
775,000
+258,000
+50% +$3.5M
TBIO
77
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$10.3M 0.4%
1,009,179
– –
QTTB icon
78
Q32 Bio
QTTB
$20.4M
$10.3M 0.4%
20,556
-4,444
-18% -$2.22M
ACRS icon
79
Aclaris Therapeutics
ACRS
$227M
$10.2M 0.39%
1,700,000
+370,600
+28% +$2.22M
FRPT icon
80
Freshpet
FRPT
$2.7B
$9.94M 0.38%
235,000
– –
ODT
81
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$9.84M 0.38%
445,000
– –
AXNX
82
DELISTED
Axonics, Inc. Common Stock
AXNX
$9.58M 0.37%
400,000
– –
CBAY
83
DELISTED
Cymabay Therapeutics
CBAY
$9.5M 0.37%
715,000
+101,396
+17% +$1.35M
NVCR icon
84
NovoCure
NVCR
$1.37B
$9.39M 0.36%
195,000
– –
CHRS icon
85
Coherus Oncology, Inc. Common Stock
CHRS
$150M
$9.14M 0.35%
670,000
– –
ASMB icon
86
Assembly Biosciences
ASMB
$183M
$8.86M 0.34%
37,500
– –
HRTX icon
87
Heron Therapeutics
HRTX
$201M
$8.55M 0.33%
350,000
-175,000
-33% -$4.28M
IFRX icon
88
InflaRx
IFRX
$112M
$8.5M 0.33%
225,000
+7,100
+3% +$268K
MYOV
89
DELISTED
Myovant Sciences Ltd.
MYOV
$8.3M 0.32%
347,500
– –
ACHN
90
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
$7.99M 0.31%
2,700,000
+375,000
+16% +$1.11M
AGIO icon
91
Agios Pharmaceuticals
AGIO
$2.09B
$7.92M 0.31%
+117,500
New +$7.92M
MRSN icon
92
Mersana Therapeutics
MRSN
$34M
$7.36M 0.28%
56,000
+16,000
+40% +$2.1M
CMTA
93
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
$7.18M 0.28%
275,000
– –
BLUE
94
DELISTED
bluebird bio
BLUE
$7.08M 0.27%
3,474
– –
FPRX
95
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$6.77M 0.26%
505,000
– –
SPRO icon
96
Spero Therapeutics
SPRO
$121M
$6.73M 0.26%
525,000
– –
CO
97
DELISTED
Global Cord Blood Corporation
CO
$6.49M 0.25%
925,000
– –
SYRE icon
98
Spyre Therapeutics
SYRE
$1.03B
$6.44M 0.25%
32,000
+6,000
+23% +$1.21M
CLVS
99
DELISTED
Clovis Oncology, Inc.
CLVS
$6.35M 0.25%
256,000
– –
RYTM icon
100
Rhythm Pharmaceuticals
RYTM
$6.78B
$5.93M 0.23%
216,500
– –
2 3
4
5 6